On May 21, 2025, Alumis Inc. completed its merger with ACELYRIN, Inc., converting each ACELYRIN share into 0.4814 shares of Alumis common stock. This merger makes ACELYRIN a wholly owned subsidiary of Alumis and includes changes to its board of directors.